Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

    Funds basic research on the harmful acute and delayed effects of ultra-potent synthetic opioids like fentanyl, including combinations, to develop countermeasures.

    OverviewSimilar Grants
    OverviewSimilar Grants

    CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

    NIH supports basic research on how toxic chemicals injure skin to spur discovery and early development of broad-spectrum medical countermeasures; clinical trials are not allowed.

    HHS-NIH11Due Oct 5, 2027$1,500,000

    Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

    NIH funds research on radiation and chemical injuries, injury models, diagnostics, and medical countermeasures for radiological, nuclear, or chemical emergencies; clinical trials are not allowed.

    HHS-NIH11Due Oct 8, 2027$10,000,000

    Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

    Supports preclinical and clinical research to develop interventions to prevent or treat substance use disorders and overdose, advancing candidates toward regulatory approval or clinical adoption.

    HHS-NIH11Due Feb 22, 2027$15,000,000

    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

    Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.

    HHS-NIH11Due Dec 16, 2026$350,000

    Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

    This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.

    HHS-NIH11Due Dec 3, 2026· 17d$275,000